Drug companies testing new medicines to combat opioid use disorder can use new methods to determine whether their drugs will work, such as by measuring patients’ ability to resume everyday life.
But companies will need to run larger studies to get their treatments across the finish line.
The Food and Drug Administration issued final guidance Thursday to encourage the pharmaceutical industry to come up with new ways to treat opioid use disorder, which remains one of the nation’s top public health crises and could be further exacerbated by the pandemic. There are three medications on the market to treat ...